Testing effectiveness (Phase 2)UnknownNCT00003327What this trial is testingPaclitaxel in Treating Patients With Recurrent or Refractory Head and Neck CancerWho this might be right forHead and Neck Cancer Theradex 60
Testing effectiveness (Phase 2)Study completedNCT00330382What this trial is testingBowman-Birk Inhibitor Concentrate in Preventing Cancer in Patients With Oral LeukoplakiaWho this might be right forLip and Oral Cavity CancerOral LeukoplakiaOropharyngeal Cancer+1 more National Cancer Institute (NCI) 325
Not applicableStudy completedNCT00693550What this trial is testingContact Allergies to Dental Metal as a Possible Risk Factor for Oral CancerWho this might be right forHead and Neck Cancer Mayo Clinic 115
Testing effectiveness (Phase 2)Ended earlyNCT02196168What this trial is testingCisplatin With or Without WEE1 Inhibitor MK-1775 in Treating Patients With Recurrent or Metastatic Head and Neck CancerWho this might be right forRecurrent Hypopharyngeal Squamous Cell CarcinomaRecurrent Laryngeal Squamous Cell CarcinomaRecurrent Laryngeal Verrucous Carcinoma+26 more National Cancer Institute (NCI) 6
Not applicableStudy completedNCT00002520What this trial is testingPhysician-Initiated Stop-Smoking Program for Patients Receiving Treatment for Early-Stage CancerWho this might be right forBladder CancerBreast CancerColorectal Cancer+7 more Eastern Cooperative Oncology Group 434
Not applicableStudy completedNCT04540588What this trial is testingRetreatment With Intratumoral Diffusing Alpha Radiation EmittersWho this might be right forSkin CancerMucosal Neoplasm of Oral CavitySoft Tissue Neoplasm Alpha Tau Medical LTD. 2
Not applicableStudy completedNCT04277273What this trial is testingCharacteristics of a Maxillofacial Prosthesis Consultation Within Assistance Publique - Hopitaux de ParisWho this might be right forHead and Neck NeoplasmCleft PalateCleft Lip Assistance Publique - Hôpitaux de Paris 83
Testing effectiveness (Phase 2)Looking for participantsNCT05136196What this trial is testingBiCaZO: A Study Combining Two Immunotherapies (Cabozantinib and Nivolumab) to Treat Patients With Advanced Melanoma or Squamous Cell Head and Neck Cancer, an immunoMATCH Pilot StudyWho this might be right forClinical Stage III Cutaneous Melanoma AJCC v8Clinical Stage III HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8Clinical Stage IV Cutaneous Melanoma AJCC v8+22 more National Cancer Institute (NCI)
Testing effectiveness (Phase 2)Study completedNCT00524017What this trial is testingCetuximab in Treating Patients With Precancerous Lesions of the Upper Aerodigestive TractWho this might be right forHead and Neck CancerPrecancerous Condition Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 35
Not applicableUnknownNCT00415298What this trial is testingAP5346 or Oxaliplatin in Treating Patients With Metastatic and/or Unresectable Recurrent Head and Neck CancerWho this might be right forHead and Neck Cancer University of California, San Diego 12
Large-scale testing (Phase 3)Study completedNCT00004234What this trial is testingOral Mucositis in Patients Receiving Radiation Therapy for Cancer of the Mouth, Pharynx, or LarynxWho this might be right forHead and Neck CancerOral Complications NCIC Clinical Trials Group
Testing effectiveness (Phase 2)Study completedNCT00021047What this trial is testingEpirubicin, Carboplatin, and Capecitabine in Treating Patients With Unresectable Locally Advanced, Metastatic, or Recurrent Solid TumorWho this might be right forEsophageal CancerExtrahepatic Bile Duct CancerGastric Cancer+3 more National Institutes of Health Clinical Center (CC)
Early research (Phase 1)Study completedNCT00470496What this trial is testingPhotodynamic Therapy Using HPPH in Treating Patients Undergoing Surgery for Primary or Recurrent Head and Neck CancerWho this might be right forRecurrent Adenoid Cystic Carcinoma of the Oral CavityRecurrent Basal Cell Carcinoma of the LipRecurrent Esthesioneuroblastoma of the Paranasal Sinus and Nasal Cavity+52 more Roswell Park Cancer Institute 15
Very early researchActive Not RecruitingNCT02790853What this trial is testingMultimodal Imaging for Surveillance in Patients With Oral Potentially Malignant DisordersWho this might be right forDysplasiaLip and Oral Cavity CarcinomaOral Disorder+1 more M.D. Anderson Cancer Center 63
Testing effectiveness (Phase 2)WithdrawnNCT00095641What this trial is testingS0225 Capecitabine in Treating Patients Who Have Undergone Surgery for Locally Recurrent or Persistent Head and Neck CancerWho this might be right forRecurrent Squamous Cell Carcinoma of the Lip and Oral CavityRecurrent Squamous Cell Carcinoma of the Paranasal Sinus and Nasal CavityRecurrent Squamous Cell Carcinoma of the Hypopharynx+2 more SWOG Cancer Research Network
Early research (Phase 1)Study completedNCT00003430What this trial is testingL-778,123 in Treating Patients With Recurrent or Refractory Solid TumorsWho this might be right forHead and Neck CancerUnspecified Adult Solid Tumor, Protocol Specific Memorial Sloan Kettering Cancer Center 40
Testing effectiveness (Phase 2)Study completedNCT02123511What this trial is testingAcetylcysteine Rinse in Reducing Saliva Thickness and Mucositis in Patients With Head and Neck Cancer Undergoing Radiation TherapyWho this might be right forMucositisOral ComplicationsRecurrent Adenoid Cystic Carcinoma of the Oral Cavity+80 more Mayo Clinic 34
Not applicableStudy completedNCT00482872What this trial is testingGermline Mutations in Patients With Head and Neck Cancer and a Family History of CancerWho this might be right forHead and Neck Cancer Vanderbilt University Medical Center 400
Early research (Phase 1)Study completedNCT00083057What this trial is testingGefitinib, Paclitaxel, and Radiation Therapy in Treating Patients With Advanced or Recurrent Squamous Cell Carcinoma of the Head and NeckWho this might be right forHead and Neck Cancer National Institutes of Health Clinical Center (CC) 30
Testing effectiveness (Phase 2)Ended earlyNCT00646659What this trial is testingCetuximab, Combination Chemotherapy, and Radiation Therapy in Treating Patients With Newly Diagnosed Stage III or Stage IV Head and Neck Cancer That Cannot Be Removed By SurgeryWho this might be right forHead and Neck Cancer European Organisation for Research and Treatment of Cancer - EORTC 47